This article was originally published in The Gray Sheet
Comments are due by July 18 on guidance documents for 510(k) submissions for permanent pacemaker leads, vascular prostheses, annuloplasty rings, extracorporeal blood circuit defoamers, cardiopulmonary bypass arterial line blood filters and oxygenators. The six devices were among 38 preamendments devices slated for reclassification from Class III to Class II in a March 15, 1999 proposed rule. Reclassification of the six devices has been put on hold, however, until the guidance documents are finalized (1"The Gray Sheet" June 28, 1999, p. 21)
You may also be interested in...
FDA is postponing the downclassification from Class III to Class II of six cardiovascular devices pending receipt of public comments on guidance documents intended to serve as special controls for the devices.
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.